Brenda R Lemos

Effects of AVX-470, an Oral, Locally Acting Anti-Tumour Necrosis Factor Antibody, on Tissue Biomarkers in Patients with Active Ulcerative Colitis.

D. Tracey, R. Burton, K. Bhol, 2016, Journal of Crohn's & colitis.

AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial.

S. Vermeire, S. Spence, R. Pruitt, 2016, Journal of Crohn's & colitis.

AVX-470: A Novel Oral Anti-TNF Antibody with Therapeutic Potential in Inflammatory Bowel Disease

A. Holdorf, D. Tracey, G. Lyng, 2013, Inflammatory bowel diseases.